Accelerated Preclinical Paths to Support Rapid Development of COVID-19 Therapeutics

When SARS-CoV-2 emerged at the end of 2019, no approved therapeutics or vaccines were available. An urgent need for countermeasures during this crisis challenges the current paradigm of traditional drug discovery and development, which usually takes years from start to finish. Approaches that accele...

Descripción completa

Detalles Bibliográficos
Autores principales: Grobler, Jay A., Anderson, Annaliesa S., Fernandes, Prabhavathi, Diamond, Michael S., Colvis, Christine M., Menetski, Joseph P., Alvarez, Rosa M., Young, John A.T., Carter, Kara L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2020
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528945/
https://www.ncbi.nlm.nih.gov/pubmed/33152278
http://dx.doi.org/10.1016/j.chom.2020.09.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7528945/
https://www.ncbi.nlm.nih.gov/pubmed/33152278
http://dx.doi.org/10.1016/j.chom.2020.09.017

Ejemplares similares